| RS1182846113 |
KIF15
|
Health Risk |
Likely risk allele |
Pulmonary fibrosis, Pulmonary fibrosis |
| RS1182853719 |
AMHR2
|
Health Risk |
Likely pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS1182864166 |
BBS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 1 |
| RS1182889391 |
TALDO1
|
Health Risk |
Pathogenic |
TALDO1-related disorder, Deficiency of transaldolase |
| RS1182894684 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, DLG4-related disorder |
| RS1182896077 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1182900059 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1182907194 |
TGFBR2
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Familial thoracic aortic aneurysm and aortic dissection, Diabetic retinopathy |
| RS1182909497 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1182940646 |
RSPH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 12 |
| RS1182948401 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS1182951086 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1182982672 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS1182983579 |
KLHL7
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1182984115 |
CAV3
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1183001223 |
HIVEP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1183009408 |
TBC1D24
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 65, Developmental and epileptic encephalopathy |
| RS1183026416 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1183062277 |
TTC21B
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Jeune thoracic dystrophy |
| RS1183074086 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Stargardt disease |
| RS1183076483 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS1183077355 |
TBCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, infantile |
| RS1183090232 |
RSRC1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 70 |
| RS1183100703 |
ASNS
|
Health Risk |
Pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS1183113572 |
PHOX2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Haddad syndrome, Hereditary cancer-predisposing syndrome |
| RS1183121064 |
TRAF3IP1
|
Health Risk |
Pathogenic |
— |
| RS1183145967 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1183164202 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1183167782 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS1183175645 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1183229867 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1183237509 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1183249870 |
WDR19
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 5, Senior-Loken syndrome 8 |
| RS1183256870 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1183257496 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis 3 |
| RS1183278712 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Sick sinus syndrome 2, autosomal dominant |
| RS1183281205 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1183285612 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS1183300636 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS1183324381 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS1183338050 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1183339720 |
TRPM1
|
Health Risk |
Pathogenic |
— |
| RS1183351612 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS1183354903 |
IFT172
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS1183355532 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS1183365510 |
MKS1
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1183383313 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1183386473 |
SYN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, X-linked 1 |
| RS1183400865 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1183403793 |
RNF170
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant sensory ataxia 1, Spastic paraplegia 85 |
| RS1183407733 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS1183420702 |
COQ4
|
Health Risk |
Likely pathogenic |
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome |
| RS1183423966 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS1183456608 |
AGTPBP1
|
Health Risk |
Pathogenic |
Neurodegeneration, childhood-onset |
| RS1183489363 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1183501213 |
TRPM1
|
Health Risk |
Pathogenic |
— |
| RS1183505712 |
LARS2
|
Health Risk |
Likely pathogenic |
— |
| RS1183515598 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS1183519794 |
LAMC2
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa, junctional 3A |
| RS1183527120 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS1183532981 |
AMH
|
Health Risk |
Pathogenic |
Persistent Mullerian duct syndrome, Persistent Mullerian duct syndrome |
| RS1183556572 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1183559927 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1183568138 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1183577696 |
PTH
|
Health Risk |
Pathogenic |
— |
| RS1183620642 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS1183621605 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS1183634153 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS1183645965 |
CYP2U1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 56, Hereditary spastic paraplegia 56 |
| RS1183655796 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Anterior segment dysgenesis |
| RS11836796 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Joubert syndrome |
| RS11837584 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
von Willebrand disease type 3, von Willebrand disease type 1 |
| RS1183781456 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1183794501 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1183804155 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary breast ovarian cancer syndrome |
| RS1183811071 |
UGT1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1183812590 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1183818307 |
MLC1
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS1183827513 |
F2
|
Health Risk |
Pathogenic |
Congenital prothrombin deficiency, Congenital prothrombin deficiency |
| RS1183832067 |
RFX5
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1183838086 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS1183851640 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1183854395 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1183869568 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS1183890194 |
TYR
|
Health Risk |
Pathogenic |
— |
| RS1183892581 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1183899324 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1183901221 |
MESP2
|
Health Risk |
Likely pathogenic |
— |
| RS1183902447 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS1183908844 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1183937142 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS11839380 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1183957540 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 39 |
| RS1183958961 |
COL4A3
|
Health Risk |
Likely pathogenic |
Benign familial hematuria, Autosomal dominant Alport syndrome |
| RS1183963868 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1183969284 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1183971719 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS1183978180 |
GDAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4A, Inborn genetic diseases |
| RS1183979115 |
CDHR1
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 15, Cone-rod dystrophy 15 |
| RS1183981489 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |